ixazomib plus lenalidomide ^Investors

TakedaThe drug was developed by Takeda. In the US, it is approved since November 2015, and in the EU since November 2016. Ixazomib is used in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma in adults after at least one prior - ?